R.E.B.E.L. EM – Monkeypox…The Basics
In recent weeks, clusters of cases have been described in several countries prompting us to revisit this topic as it is not one we typically deal with in the ED.
R.E.B.E.L. EM – Monkeypox…The Basics Read More »
In recent weeks, clusters of cases have been described in several countries prompting us to revisit this topic as it is not one we typically deal with in the ED.
R.E.B.E.L. EM – Monkeypox…The Basics Read More »
This practice is also commonly applied to patients with non-traumatic causes of obtundation. However, the evidence behind this practice is not clear, prompting many to re-examine this oft-repeated lesson.
R.E.B.E.L. EM – Dogmalysis: GCS <8, Then Intubate? Read More »
This post will serve as a summary of thrombosis and hemoglobin in regard to COVID-19.
R.E.B.E.L. EM – COVID-19: Thrombosis and Hemoglobin Read More »
While not as common, auricular hematomas are equally important to both understand and know how to manage.
R.E.B.E.L. EM – Auricular Hematoma Management Read More »
Traditionally, vasopressor infusions have been done through central venous catheters (CVCs) due to the hypothetical risk of extravasation injury to extremities when given through peripheral IVs.
R.E.B.E.L. EM – Peripheral Pressors: 6 Pearls to Not F*#k Up the Arm Read More »
Despite decades of experience with endotracheal intubation, we continue to find approaches to improving the process of how we intubate.
R.E.B.E.L. EM – How to Intubate the Critically Ill Like a Boss Read More »
For this EM Mindset: COVID-19 edition, we have thoughts from a community EM doc and founder of REBEL EM: Salim Rezaie.
EM Mindset: COVID-19 Edition – A Community EM Doc’s Perspective Read More »
Fast forward to today and we are finding all kinds of uses for TXA other than trauma including post-partum hemorrhage, epistaxis, hemoptysis, gastrointestinal hemorrhage, and many more.
R.E.B.E.L. EM – Tranexamic Acid (TXA) for Everything that Bleeds? Read More »
CCTA has become a popular modality in the ED setting to assess anatomic atherosclerotic disease in patients presenting with chest pain. Advocates of CCTA feel that CCTA has a greater accuracy in identifying obstructive coronary artery disease and identification of high-risk disease compared to standard physiologic testing. However, many published trials on CCTA were not adequately powered to evaluate patient oriented end points.